EUVIMEDEUVIMED entdecken
Crossref

Integrated network pharmacology, molecular docking, and experimental validation reveal the therapeutic potential of ginger jujube tea against colorectal cancer

Xing-Yu Nie, Li-Yi Fang, Yu-Qing Cui, Lin Jin, Cai-Xin Liang, Jun-Feng Zhang

Cancer Advances · 2026 · 9 · e26018

DOI: 10.53388/2026926018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Advances, 2026. Verfasst von Xing-Yu Nie und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) is one of the most common and lethal malignancies worldwide, with rising incidence and limited therapeutic options. Traditional Chinese medicine (TCM) formulations, known for their multi-component and multi-target synergistic actions, offer a promising alternative or adjunctive strategy. Ginger jujube tea (GJT), a classic TCM decoction, has been historically used for gastrointestinal regulation, yet its anti-CRC efficacy and pharmacological mechanisms remain unexplored.

Methods

An integrated network pharmacology approach was employed to predict the active constituents of GJT and their potential CRC-related targets, followed by molecular docking to validate key compound-target interactions. The predicted pathways were further investigated through in vitro experiments using CRC cell lines (proliferation assays, reactive oxygen species (ROS) detection, apoptosis evaluation) and in vivo studies in a CRC xenograft mouse model, where tumor growth inhibition, safety profiles, and mechanistic markers (MAPK1, ESR1, HIF1A, PI3K-AKT pathway) were assessed.

Results

Network pharmacology and molecular docking identified quercetin, naringenin, and other bioactive compounds as major active components, with core targets including AKT1, MAPK1, and ESR1 , predominantly enriched in the PI3K-AKT signaling pathway. In vitro , GJT dose-dependently suppressed CRC cell proliferation, significantly elevated intracellular ROS levels, and induced apoptosis. In vivo , GJT at 10 g/kg achieved a robust tumor growth inhibition rate of 64.69 ± 6.95% without observable toxicity, as confirmed by biochemical and histopathological analyses. Mechanistically, GJT downregulated MAPK1, ESR1, and HIF1A expression and inhibited PI3K-AKT pathway activation, corroborating the network-based predictions.

Conclusion

GJT exerts potent anti-CRC effects through a multi-component, multi-target, and multi-pathway mechanism, consistent with the holistic philosophy of TCM. The favorable efficacy and safety profile support its potential as a complementary therapeutic candidate for CRC, warranting further clinical investigation.

Zitieren

APA

Nie, X., Fang, L., Cui, Y., Jin, L., Liang, C., & Zhang, J. (2026). Integrated network pharmacology, molecular docking, and experimental validation reveal the therapeutic potential of ginger jujube tea against colorectal cancer. Cancer Advances, 9(0), e26018. https://doi.org/10.53388/2026926018

Vancouver

Nie X, Fang L, Cui Y, Jin L, Liang C, Zhang J. Integrated network pharmacology, molecular docking, and experimental validation reveal the therapeutic potential of ginger jujube tea against colorectal cancer. Cancer Advances. 2026;9(0):e26018. doi:10.53388/2026926018

BibTeX
@article{Nie2026,
  author = {Nie, Xing-Yu and Fang, Li-Yi and Cui, Yu-Qing and Jin, Lin and Liang, Cai-Xin and Zhang, Jun-Feng},
  title = {Integrated network pharmacology, molecular docking, and experimental validation reveal the therapeutic potential of ginger jujube tea against colorectal cancer},
  journal = {Cancer Advances},
  year = {2026},
  volume = {9},
  number = {0},
  pages = {e26018},
  doi = {10.53388/2026926018}
}
Kostenlos starten →